Gelteq Limited (NASDAQ:GELS – Get Free Report)’s share price dropped 1.7% on Thursday . The stock traded as low as $1.66 and last traded at $1.72. Approximately 33,333 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 4,032,427 shares. The stock had previously closed at $1.75.
Gelteq Stock Down 1.7%
The company’s fifty day moving average price is $1.80 and its two-hundred day moving average price is $1.81.
Institutional Trading of Gelteq
A hedge fund recently bought a new stake in Gelteq stock. Citadel Advisors LLC acquired a new position in Gelteq Limited (NASDAQ:GELS – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 23,748 shares of the company’s stock, valued at approximately $55,000. Citadel Advisors LLC owned approximately 0.25% of Gelteq as of its most recent SEC filing.
About Gelteq
Gelteq Inc is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition.
Recommended Stories
- Five stocks we like better than Gelteq
- What Are Some of the Best Large-Cap Stocks to Buy?
- Rigetti Computing: Cantor’s Bullish Call May Be Just the Start
- Election Stocks: How Elections Affect the Stock Market
- Big Bank Buybacks: Morgan Stanley, Citi, & Wells Fargo Lead
- How to Short a Stock in 5 Easy Steps
- 3 Top Stocks Under $20 Riding the “Made in America” Wave
Receive News & Ratings for Gelteq Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gelteq and related companies with MarketBeat.com's FREE daily email newsletter.
